Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
120 participants
INTERVENTIONAL
2022-12-20
2023-01-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Pleiotropic Effects of Atorvastatin When Combined With Common Antihypertenisve Medications.
NCT00656331
Pleiotropic Effects of Atorvastatin in High Cardiovascular Risk Patients
NCT01013103
Amlodipine/Atorvastatin Combination to Reduce the Health Risk of High Blood Pressure and High Cholesterol Levels
NCT00143234
Effects of Atorvastatin on Blood Pressure and Urinary Albumin Excretion
NCT01126684
A Randomized Study To Evaluate Efficacy And Safety Of A Fixed Combination Therapy Of Amlodipine And Atorvastatin
NCT00530946
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Amlopdipine only
Newly diagnosed hypertensive patients who will be given only amlodipine.
Amlodipine 5 MG Oral Tablet
one group will be given only Amlodipine 5MG once daily
Amlodipine and Atorvastatin
Newly diagnosed hypertensive patients who will be given Amlodipine and Atorvastatin.
Amlodipine 5 MG / Atorvastatin 10 MG Oral Tablet
one group will be given Amlodipine 5mg plus Atorvastatin 10MG once daily
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Amlodipine 5 MG Oral Tablet
one group will be given only Amlodipine 5MG once daily
Amlodipine 5 MG / Atorvastatin 10 MG Oral Tablet
one group will be given Amlodipine 5mg plus Atorvastatin 10MG once daily
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
35 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ayub Teaching Hospital
OTHER
Khyber Medical University Peshawar
OTHER
Himayat Ullah
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Himayat Ullah
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shaqra University
Shaqra, Riyadh Region, Saudi Arabia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DIR/KMU-EB/EA/000560
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.